(Q40755909)

English

Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer

scientific article published on December 1990

In more languages
default values for all languages
No label defined

No description defined

Statements

Phase II feasibility study of high dose epirubicin-based regimens for untreated patients with small-cell lung cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit